Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

Alternatives to carbapenems in ESBL-producing Escherichia coli infections

(2013) D. Fournier et al.   MEDECINE ET MALADIES INFECTIEUSES

Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms

(2012) Elizabeth A. Neuner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection

(2012) Meltem Isikgoz Tasbakan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum  -lactamase-producing Escherichia coli

(2012) N. Lampri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: Prevalence, β-lactamase distribution, phylogroups, and co-resistance

(2012) Dennis Schrøder Hansen et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections

(2012) Yasser Madani et al.   Primary Care Respiratory Journal

Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae

(2011) EMILIA TITELMAN et al.   APMIS

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

(2011) Kalpana Gupta et al.   CLINICAL INFECTIOUS DISEASES

In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli

(2011) M. Tärnberg et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella pneumoniae

(2011) Emilia Titelman et al.   Microbial Drug Resistance

Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum- -Lactamase-Producing Escherichia coli

(2010) S. Auer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections

(2009) Gian Carlo Schito et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins

(2009) M. Wootton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE